Publications

Cancer cell

Learning the language of T cell receptors through large-scale screening.

09-06-2025

JCI insight

G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor.

09-06-2025

Molecular cell

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

05-06-2025

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

05-06-2025

Cellular and molecular life sciences : CMLS

CD151 interacts with integrin beta 2 in B cell lymphomas.

04-06-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

03-06-2025

European journal of cancer (Oxford, England : 1990)

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

03-06-2025

European journal of cancer (Oxford, England : 1990)

Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.

03-06-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

03-06-2025

The Journal of clinical investigation

The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression.

02-06-2025

Radiology

A Data-Centric Approach to Deep Learning for Brain Metastasis Analysis at MRI.

01-06-2025

Nature

PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease.

01-06-2025

Clinical genitourinary cancer

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

01-06-2025

British journal of cancer

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

01-06-2025

British journal of cancer

Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.

01-06-2025

Clinical colorectal cancer

Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands.

01-06-2025

The Lancet. Oncology

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

01-06-2025

Cancer epidemiology

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

01-06-2025

ESMO open

Financial toxicity and socioeconomic impact of cancer in Europe.

01-06-2025

Key Publication

The Lancet. Oncology

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study.

01-06-2025

Nature biomedical engineering

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.

01-06-2025

ESMO real world data and digital oncology

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.

01-06-2025

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

01-06-2025

Contemporary clinical trials communications

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

01-06-2025

NAR genomics and bioinformatics

Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data.

01-06-2025

Cancer reports (Hoboken, N.J.)

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report.

01-06-2025

European journal of epidemiology

Cancer risk after in utero exposure to diethylstilbestrol.

01-06-2025

Biomedical chromatography : BMC

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

01-06-2025

JCO oncology practice

General Practitioners' Experiences With Implementing Colon or Prostate Cancer Survivorship Care in Primary Care: A Cross-Sectional Survey Nested Within Two Randomized-Controlled Trials.

01-06-2025

Journal of the National Cancer Center

Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype.

01-06-2025

Trends in cancer

Myeloid cell path to malignancy: insights into liver cancer.

01-06-2025

EBioMedicine

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

01-06-2025

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.

01-06-2025

Maturitas

No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).

01-06-2025

European radiology

Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis.

01-06-2025

The Lancet. Oncology

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

01-06-2025

Gastroenterology

Reply.

01-06-2025

Nature cancer

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

01-06-2025

ESMO open

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma.

01-06-2025

Breast (Edinburgh, Scotland)

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

01-06-2025

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.

01-06-2025

Oncology and therapy

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

01-06-2025

Molecular oncology

Strategies to reduce the cancer burden and improve access to effective and affordable cancer interventions in Europe.

01-06-2025

Journal of cancer survivorship : research and practice

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

01-06-2025

Journal of the National Cancer Institute

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

01-06-2025

The British journal of surgery

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

31-05-2025

NPJ breast cancer

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

29-05-2025

Journal of cancer survivorship : research and practice

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

28-05-2025

EJNMMI research

Metabolic parameters on baseline and early [¹⁸F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.

28-05-2025

Physics in medicine and biology

Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.

27-05-2025

Learning the language of T cell receptors through large-scale screening.

G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor.

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

CD151 interacts with integrin beta 2 in B cell lymphomas.

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression.

A Data-Centric Approach to Deep Learning for Brain Metastasis Analysis at MRI.

PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease.

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.

Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands.

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

Financial toxicity and socioeconomic impact of cancer in Europe.

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study.

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data.

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report.

Cancer risk after in utero exposure to diethylstilbestrol.

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

General Practitioners' Experiences With Implementing Colon or Prostate Cancer Survivorship Care in Primary Care: A Cross-Sectional Survey Nested Within Two Randomized-Controlled Trials.

Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype.

Myeloid cell path to malignancy: insights into liver cancer.

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.

No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).

Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis.

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Reply.

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma.

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

Strategies to reduce the cancer burden and improve access to effective and affordable cancer interventions in Europe.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.

Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.

This site uses cookies

Metabolic parameters on baseline and early [¹⁸F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.